Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Hemosol (HML.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Hemosol (HML.TO)

0.00
-0.00 (0.00%)
0 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Hemosol(HML.TO)

Nov 01, 2002
Has some problems. Cash position is down to one year. If they issue stocks to rais cash, it will dilute these shares further.
Photo of Robert FloydRobert FloydUnlock Rating
$1.29

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Oct 02, 2002
Very risky situation. May have to dilute stock by issuing more shares.
Photo of Mike WeirMike WeirUnlock Rating
$1.13

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Sep 20, 2002
Could run out of cash.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$0.85

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Aug 20, 2002
Had delays in getting product out. A lot of cash. Risky unless you buy several small pharmaceuticals to spread the risk.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$1.07

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Aug 19, 2002
Has cash burn and has to raise money. Speculative.
Photo of David BaskinDavid BaskinUnlock Rating
$1.03

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

May 02, 2002
Have had a tough time getting approval. Competition is growing. Future is uncertain.
Photo of Bruce CooperBruce CooperUnlock Rating
$3.75

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Apr 29, 2002
Hard to like.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$3.90

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Apr 25, 2002
Disappointed with their product results. High burn rate.
Photo of Robert FloydRobert FloydUnlock Rating
$4.00

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Apr 18, 2002
Has disappointed. Not convinced about the needs for blood substitute.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$4.60

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Apr 03, 2002
Treat as a trading stock. No value right now.
Photo of David DriscollDavid DriscollUnlock Rating
$4.58

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Apr 02, 2002
Only has one drug. Needds more diversification.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$4.62

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Mar 21, 2002
Approval of Hemolink was denied. No revenues or earnings.
Photo of Bruce CooperBruce CooperUnlock Rating
$4.20

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Mar 21, 2002
Too much competition.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$4.20

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Hemosol(HML.TO)

Mar 20, 2002
At a good price and a good buy for an aggressive investor.
Photo of Rob CallanderRob CallanderUnlock Rating
$5.88

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Hemosol(HML.TO)

Feb 19, 2002
A one trick pony. Speculative.
Photo of David BaskinDavid BaskinUnlock Rating
$6.29

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 16 to 30 of 78 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica